A randomized phase II study of docetaxel with or without vandetanib in recurrent or metastatic squamous cell carcinoma of head and neck (SCCHN)Sewanti Limaye, Robert I. Haddad, Sihai Dave Zhao et al.|Oral Oncology|2013Cited by 59